Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2006-11-14
2006-11-14
Swartz, Rodney P (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C424S009100, C424S009200, C424S130100, C424S164100, C424S184100, C424S234100, C424S248100, C435S029000, C435S243000, C435S253100, C436S501000
Reexamination Certificate
active
07135280
ABSTRACT:
Method of determining the efficacy of treatment for mycobacterial infection in an individual comprising determining in samples from the individual whether the level of T cells specific for a mycobacterial antigen has decreased after the treatment, thereby determining the efficacy of the treatment.
REFERENCES:
patent: WO 98/23960 (1998-06-01), None
patent: WO 00/26248 (2000-05-01), None
patent: WO 00/55194 (2000-09-01), None
patent: WO 01/04151 (2001-01-01), None
Lind, A., et al, “Mycobacterial species: immunological classification”, in, The Mycobacteria, a sourcebook, Part A, eds, Kubica and Wayne, Marcel Dekker, Inc., New York; pp. 67-82, 1984.
Magnusson, M., “Immunological classification susing sensitins”, in, The Mycobacteria, a sourcebook, Part A, eds, Kubica and Wayne, Marcel Dekker, Inc., New York, pp. 83-104, 1984.
Cambau, E., et al “Resistance to quinolones in mycobaceria”, Res. Microbiol., vol. 147, No. 1, pp. 52-59, 1996.
Lalvani et al. “Human cytolytic and interferon γ-secreting CD8+T lymphocytes specific forMycobacterium tuberculosis” Proc. Natl. Acad. Sci. USA 95:270-275 (1998).
Lalvani et al. “Rapid effector function in CD8+memory T cells” J. Exp. Med. 186:859-865 (1997).
Pathan et al. “High frequencies of circulating IFN-γ-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restrictedMycobacterium tuberculosisepitope inM. tuberculosis-infected subjects without disease” Eur. J. Immunol. 30:2713-2721 (2000).
Mustafa et al. “Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens ofMycobacterium tuberculosis” Scand. J. Immunol. 48:535-543 (1998).
Ravn et al. “Human T cells responses to the ESAT-6 antigen fromMycobacterium tuberculosis” J. Infect. Dis. 179:637-645 (1999).
Search Report dated Jul. 16, 2001 for GB0100432.4.
Dieli et al. “Sequestration of T lymphocytes to body fluids in tuberculosis: Reversal of anergy following chemotherapy” XP-002214600 J. Infect. Dis. 180:225-228 (1999).
Pathan et al. “Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in mycobacterium tuberculosis-infected individuals: Associations with clinical disease state and effect of treatment” Abstract XP-002214601 Database Accession No. NLM11673535 J. Immunol. 167:5217-5225 (2001).
Ulrichs et al. “Differential T cell responses to mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors” XP-000891644 Eur. J. Immunol. 28:3949-3958 (1998).
International Search Report dated Mar. 13, 2003.
Meister et al. “Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes fromMycobacterium tuberculosisand HIV protein sequences” Vaccine 13:581-591 (1995).
Mohagheghpour et al. “CTL response toMycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein” J. Immunol. 161:2400-2406 (1998).
Smith et al. “Human CD8 CTL specific for the mycobacterial major secreted antigen 85A” J. Immunol. 165:7088-7095 (2000).
Wilkinson et al. “38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-γ-secreting CD8 T cells in healthy contacts of tuberculosis” Immunol. 95:585-590 (1998).
Isis Innovation Limited
Nixon & Vanderhye
Swartz Rodney P
LandOfFree
Assay to determine efficacy of treatment for mycobacterial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay to determine efficacy of treatment for mycobacterial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay to determine efficacy of treatment for mycobacterial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631329